UA112539C2 - Спосіб одержання похідних 2-карбоксамідциклоаміносечовини - Google Patents

Спосіб одержання похідних 2-карбоксамідциклоаміносечовини Download PDF

Info

Publication number
UA112539C2
UA112539C2 UAA201310018A UAA201310018A UA112539C2 UA 112539 C2 UA112539 C2 UA 112539C2 UA A201310018 A UAA201310018 A UA A201310018A UA A201310018 A UAA201310018 A UA A201310018A UA 112539 C2 UA112539 C2 UA 112539C2
Authority
UA
Ukraine
Prior art keywords
compound
formula
stage
solvent
tetrahydrofuran
Prior art date
Application number
UAA201310018A
Other languages
English (en)
Ukrainian (uk)
Inventor
Бернхард Ерб
Ізабель Сильві Галлу
Флоріан Карл Кляйнбек
Original Assignee
Новартіс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA112539(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартіс Аг filed Critical Новартіс Аг
Publication of UA112539C2 publication Critical patent/UA112539C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
UAA201310018A 2011-03-03 2012-01-03 Спосіб одержання похідних 2-карбоксамідциклоаміносечовини UA112539C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Publications (1)

Publication Number Publication Date
UA112539C2 true UA112539C2 (uk) 2016-09-26

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201310018A UA112539C2 (uk) 2011-03-03 2012-01-03 Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Country Status (33)

Country Link
US (3) US9650373B2 (https=)
EP (1) EP2681192B1 (https=)
JP (1) JP6022485B2 (https=)
KR (1) KR101851421B1 (https=)
CN (2) CN103402982B (https=)
AR (2) AR088714A1 (https=)
AU (1) AU2012222346B2 (https=)
BR (1) BR112013021882A2 (https=)
CA (1) CA2828509C (https=)
CL (1) CL2013002521A1 (https=)
CO (1) CO6751286A2 (https=)
DK (1) DK2681192T3 (https=)
EA (4) EA025381B1 (https=)
EC (1) ECSP13012914A (https=)
ES (1) ES2663717T3 (https=)
GT (1) GT201300211A (https=)
HU (1) HUE036319T2 (https=)
IL (1) IL228023A (https=)
MA (1) MA34982B1 (https=)
MX (2) MX351740B (https=)
MY (1) MY163214A (https=)
NO (1) NO2681192T3 (https=)
PE (1) PE20140917A1 (https=)
PH (1) PH12013501796A1 (https=)
PL (1) PL2681192T3 (https=)
PT (1) PT2681192T (https=)
SG (1) SG192793A1 (https=)
SI (1) SI2681192T1 (https=)
TN (1) TN2013000354A1 (https=)
TW (2) TWI597279B (https=)
UA (1) UA112539C2 (https=)
WO (1) WO2012117071A1 (https=)
ZA (1) ZA201306174B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
DE60023926T2 (de) 1999-09-10 2006-07-20 Merck & Co., Inc. Tyrosin kinase inhibitoren
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
CA2639910A1 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
EP2240475B1 (en) * 2007-12-20 2013-09-25 Novartis AG Thiazole derivatives used as pi 3 kinase inhibitors
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
PH12013501796A1 (en) 2022-10-26
CA2828509C (en) 2018-11-20
DK2681192T3 (en) 2018-04-16
KR20140009432A (ko) 2014-01-22
JP6022485B2 (ja) 2016-11-09
EA032802B1 (ru) 2019-07-31
NO2681192T3 (https=) 2018-05-26
IL228023A (en) 2017-04-30
TW201247660A (en) 2012-12-01
TWI597279B (zh) 2017-09-01
CA2828509A1 (en) 2012-09-07
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
EA201691331A1 (ru) 2017-01-30
BR112013021882A2 (pt) 2016-07-19
EP2681192B1 (en) 2017-12-27
US20170240509A1 (en) 2017-08-24
EP2681192A1 (en) 2014-01-08
MX2013010132A (es) 2013-10-30
ZA201306174B (en) 2014-05-28
ES2663717T3 (es) 2018-04-16
CN106083840B (zh) 2020-01-03
CN103402982B (zh) 2016-07-13
AR123584A2 (es) 2022-12-21
PT2681192T (pt) 2018-04-02
NZ614173A (en) 2015-04-24
US20170355677A1 (en) 2017-12-14
MA34982B1 (fr) 2014-03-01
EA201892052A1 (ru) 2019-02-28
SI2681192T1 (en) 2018-04-30
US20130331579A1 (en) 2013-12-12
MX351740B (es) 2017-10-26
CN103402982A (zh) 2013-11-20
AU2012222346B2 (en) 2015-05-07
ECSP13012914A (es) 2013-11-29
SG192793A1 (en) 2013-09-30
US9650373B2 (en) 2017-05-16
PE20140917A1 (es) 2014-08-14
GT201300211A (es) 2014-12-30
AU2012222346A1 (en) 2013-08-29
PL2681192T3 (pl) 2018-06-29
TW201722916A (zh) 2017-07-01
US10059670B2 (en) 2018-08-28
AR088714A1 (es) 2014-07-02
TN2013000354A1 (en) 2015-01-20
EA201391267A1 (ru) 2014-01-30
WO2012117071A1 (en) 2012-09-07
CL2013002521A1 (es) 2014-02-14
EA201792068A2 (ru) 2018-01-31
TWI607994B (zh) 2017-12-11
CN106083840A (zh) 2016-11-09
CO6751286A2 (es) 2013-09-16
EA025381B1 (ru) 2016-12-30
IL228023A0 (en) 2013-09-30
EA201792068A3 (ru) 2018-05-31
KR101851421B1 (ko) 2018-04-23
HUE036319T2 (hu) 2018-06-28
JP2014511387A (ja) 2014-05-15
US9776966B2 (en) 2017-10-03

Similar Documents

Publication Publication Date Title
UA112539C2 (uk) Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
CA2628074C (en) Aminodihydrothiazine derivative
JPH09227527A (ja) 4−オキソイミダゾリニウム塩の製造方法
EP3798224A1 (en) Solid state forms of ixazomib citrate
ES2680933T3 (es) Métodos para la preparación de Alcaftadina
JP2002513021A (ja) 1,3−二置換−4−オキソ環式尿素の製造方法
JPH0782268A (ja) ベンゾチアジアゾール誘導体の製法
HK1189578B (en) Synthesis of 2-carboxamide cycloamino urea derivatives
HK1189578A (en) Synthesis of 2-carboxamide cycloamino urea derivatives
KR20110014613A (ko) 치환된 복소환의 제조 방법
SU507241A3 (ru) Способ получени производных теофиллина
EP1098895B1 (fr) Procede pour la preparation du sel potassique du lintitript
JP2008540675A5 (https=)
JP2562872B2 (ja) シアノ−イミダゾ−ル化合物の合成法
RU2311412C1 (ru) Способ получения 1,3-ди[4-(6-метил-4-пиримидинон-2-тио)метилфенил]адамантана
Jones 3.5. 2 Using NFSI (1) as the Electrophilic Fluorine Source
JPH0435464B2 (https=)
PL91237B1 (https=)